News

News
Other news

On Target Laboratories, Inc. Announces Results of Phase 3 Trial for Pafolacianine Sodium Injection for Intraoperative Illumination of Folate Receptor Positive Ovarian Cancer

Read full story
Partner news

Mestag Therapeutics announces collaboration with Janssen, focused on the discovery of novel fibroblast targets for the treatment of inflammatory disease

Read full story

Cue Health Announces Completion of $235 Million Private Financing to Accelerate Growth

Read full story
Other news

Aetion Closes $110M Series C Funding Round Led by Warburg Pincus

Read full story
Partner news

L'engagement de Janssen France dans l'IA et la génomique

Read full story
Partner news

Collaboration with Johnson & Johnson Innovation to jump-start search for new malaria drugs

Read full story
Partner news

Teneobio Announces Achievement of Milestone Payment as Janssen Advances Phase I Study of Bispecific JNJ-75348780 for the Treatment of NHL and CLL

Read full story
Partner news

Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza

Read full story
Other news

Amgen to Acquire Rodeo Therapeutics Corporation

Read full story

Infinite Looks Announces $4.2M Series A Funding to Champion the Active Textured Hair Community Through its Brand Sunday II Sunday

Read full story
Other news

On Target Laboratories Secures $21 Million for Development and Commercialization of Pafolacianine Sodium Injection

Read full story
Other news

Next-generation Radiopharmaceuticals Company POINT Biopharma to list on NASDAQ through merger with Research Alliance Corp. I

Read full story
Other news

Paige Secures Financing from KKR for Total Series C Funding Round of Over $125 Million

Read full story
Other news

FDA Authorizes Cue Health's COVID-19 Test for At-Home and Over The Counter Use

Read full story
Other news

TechsoMed Raises $7 Million Series B financing led by Axil Capital

Read full story